Publications by authors named "N Hail"

To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS). Comparative cross-sectional analysis. Demographic and metabolic data from Qatari women aged 18-40 years from the Qatar Biobank (97 diagnosed with PCOS, 563 controls).

View Article and Find Full Text PDF
Article Synopsis
  • High levels of Galectin 3 (LGALS3) in mesenchymal stromal cells (MSC) from acute myeloid leukemia (AML) patients are linked to poorer outcomes and increased relapse rates.
  • Using reverse phase protein analysis (RPPA), researchers found LGALS3 expression positively correlates with proteins like MYC and AKT2, indicating its role in key biological pathways, while negatively correlating with integrin beta 3 (ITGB3).
  • Targeting LGALS3 with a specific inhibitor (CBP.001) decreased AML cell survival and improved the efficacy of chemotherapy, suggesting LGALS3's critical role in AML cell behavior within the cancer microenvironment.
View Article and Find Full Text PDF

Mesenchymal stromal cells (MSC) support acute myeloid leukemia (AML) cell survival in the bone marrow (BM) microenvironment. Protein expression profiles of AML-derived MSC are unknown. Reverse phase protein array analysis was performed to compare expression of 151 proteins from AML-MSC (n=106) with MSC from healthy donors (n=71).

View Article and Find Full Text PDF

We have identified that the ganglioside GD2 is a marker for breast cancer stem cells (BCSCs), and that targeting the enzyme GD3 synthase (GD3S, which regulates GD2 biosynthesis) reduces breast tumorigenesis. The pathways regulating GD2 expression, and their anomalous functions in BCSC, are unclear. Proteomic analysis of GD2+ and GD2- cells from breast cancer cell lines revealed the activation of NFκB signaling in GD2+ cells.

View Article and Find Full Text PDF

Leukemia cells in the bone marrow must meet the biochemical demands of increased cell proliferation and also survive by continually adapting to fluctuations in nutrient and oxygen availability. Thus, targeting metabolic abnormalities in leukemia cells located in the bone marrow is a novel therapeutic approach. In this study, we investigated the metabolic role of bone marrow adipocytes in supporting the growth of leukemic blasts.

View Article and Find Full Text PDF